Biochemical connection between hepatitis C virus and liver cancer (Hepatitis C Treatment Options)
Biochemical connection between hepatitis C virus and liver cancer
Xagena Medical News - Researchers at the University of Texas Medical Branch at Galveston ( UTMB ) have identified a key biochemical connection between the hepatitis C virus and liver cancer. According to Stanley M. Lemon, the senior author of a paper, the molecular
Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved
Medical News Today - Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company's country operations in Japan, has received marketing approval for a new, additional indication for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection in

<< Home